Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hepatitis B × hepatitis B hyperimmune globulin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Failure, Acute 1 Hepatitis B 1 Fibrosis 1 Carcinoma, Hepatocellular 1

Interventions

Lamivudine 2 hepatitis B hyperimmune globulin 1 entecavir 1 bicyclol 1 adefovir dipivoxil 1 Tablets 1 Radiomics 1 Pharmaceutical Preparations 1 Nucleosides 1 Interferons 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡